title: Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts".
authors.affiliation: Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Piccini
authors.forename: Susanna R
authors.initials: SR
authors.lastname: Stevens
authors.forename: Yuchiao
authors.initials: Y
authors.lastname: Chang
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Singer
authors.forename: Yuliya
authors.initials: Y
authors.lastname: Lokhnygina
authors.forename: Alan S
authors.initials: AS
authors.lastname: Go
authors.forename: Manesh R
authors.initials: MR
authors.lastname: Patel
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Mahaffey
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Halperin
authors.forename: Günter
authors.initials: G
authors.lastname: Breithardt
authors.forename: Graeme J
authors.initials: GJ
authors.lastname: Hankey
authors.forename: Werner
authors.initials: W
authors.lastname: Hacke
authors.forename: Richard C
authors.initials: RC
authors.lastname: Becker
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Nessel
authors.forename: Keith A A
authors.initials: KA
authors.lastname: Fox
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy*; D004617:Embolism / Q000517:prevention & control*; D015951:Factor Xa / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009025:Morpholines / Q000008:administration & dosage*; D020521:Stroke / Q000517:prevention & control*; D013876:Thiophenes / Q000008:administration & dosage*; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D009025:Morpholines; D013876:Thiophenes; D014812:Vitamin K; D015951:Factor Xa